These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12688368)

  • 1. Gastrin agonists and antagonists.
    Black JW; Kalindjian SB
    Pharmacol Toxicol; 2002 Dec; 91(6):275-81. PubMed ID: 12688368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of biologic gastrin activity of compound CI-988 in the isolated, vascularly perfused rat stomach.
    Marvik R; Sandvik AK; Waldum HL
    Scand J Gastroenterol; 1997 Jun; 32(6):519-22. PubMed ID: 9200280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformationally constrained CCK4 analogues incorporating IBTM and BTD beta-turn mimetics.
    Martín-Martínez M; De la Figuera N; Latorre M; García-López MT; Cenarruzabeitia E; Del Río J; González-Muñiz R
    J Med Chem; 2005 Dec; 48(24):7667-74. PubMed ID: 16302807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpeptide cholecystokinin-2 receptor agonists.
    Kalindjian SB; Dunstone DJ; Low CM; Pether MJ; Roberts SP; Tozer MJ; Watt GF; Shankley NP
    J Med Chem; 2001 Apr; 44(8):1125-33. PubMed ID: 11312913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.
    Faust R; Garratt PJ; Jones R; Yeh LK; Tsotinis A; Panoussopoulou M; Calogeropoulou T; Teh MT; Sugden D
    J Med Chem; 2000 Mar; 43(6):1050-61. PubMed ID: 10737738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.
    Corringer PJ; Weng JH; Ducos B; Durieux C; Boudeau P; Bohme A; Roques BP
    J Med Chem; 1993 Jan; 36(1):166-72. PubMed ID: 8421283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells.
    Lindström E; Björkqvist M; Håkanson R
    Br J Pharmacol; 1999 May; 127(2):530-6. PubMed ID: 10385255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of gastrin antagonists, analogues of the C-terminal tetrapeptide of gastrin, by introduction of a beta-homo residue.
    Rodriguez M; Fulcrand P; Laur J; Aumelas A; Bali JP; Martinez J
    J Med Chem; 1989 Mar; 32(3):522-8. PubMed ID: 2918498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel C-terminal gastrin antagonists. Synthesis and biological activity.
    Yasui A; Douglas AJ; Walker B; Magee DF; Murphy RF
    Int J Pept Protein Res; 1990 Apr; 35(4):301-5. PubMed ID: 2345051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-antigastrin activity relationships of new (R)-4-benzamido-5-oxopentanoic acid derivatives.
    Makovec F; Peris W; Revel L; Giovanetti R; Mennuni L; Rovati LC
    J Med Chem; 1992 Jan; 35(1):28-38. PubMed ID: 1732532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis.
    Håkanson R; Ding XQ; Norlén P; Lindström E
    Regul Pept; 1999 Mar; 80(1-2):1-12. PubMed ID: 10235629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the melatonin receptor. 5. Melatonin agonists and antagonists derived from tetrahydrocyclopent[b]indoles, tetrahydrocarbazoles and hexahydrocyclohept[b]indoles.
    Davies DJ; Garratt PJ; Tocher DA; Vonhoff S; Davies J; Teh MT; Sugden D
    J Med Chem; 1998 Feb; 41(4):451-67. PubMed ID: 9484496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial requirements of the antagonist binding site of the NK2 receptor.
    Ali MA; Bhogal N; Fishwick CW; Findlay JB
    Bioorg Med Chem Lett; 2001 Mar; 11(6):819-22. PubMed ID: 11277528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaffold hopping with molecular field points: identification of a cholecystokinin-2 (CCK2) receptor pharmacophore and its use in the design of a prototypical series of pyrrole- and imidazole-based CCK2 antagonists.
    Low CM; Buck IM; Cooke T; Cushnir JR; Kalindjian SB; Kotecha A; Pether MJ; Shankley NP; Vinter JG; Wright L
    J Med Chem; 2005 Nov; 48(22):6790-802. PubMed ID: 16250638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of C-terminal tri- and tetrapeptide fragments that inhibit gastrin activity.
    Martinez J; Bali JP; Magous R; Laur J; Lignon MF; Briet C; Nisato D; Castro B
    J Med Chem; 1985 Mar; 28(3):273-8. PubMed ID: 3973899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytosolic Ca2+ evaluation in rabbit parietal cells: a novel method to screen gastrin receptor antagonists.
    Letari O; Mennuni L; Revel L; Colombo S; Makovec F
    Eur J Pharmacol; 1996 Jun; 306(1-3):325-33. PubMed ID: 8813647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the biologically active structures of cholecystokinin, little gastrin, and enkephalin in the gastrointestinal system.
    Pincus MR; Carty RP; Chen J; Lubowsky J; Avitable M; Shah D; Scheraga HA; Murphy RB
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4821-5. PubMed ID: 3037525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives.
    Weng JH; Blommaert AG; Moizo L; Bado A; Ducos B; Böhme A; Garbay C; Roques BP
    Bioorg Med Chem; 1996 Apr; 4(4):563-73. PubMed ID: 8735845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
    Kołaczkowski M; Marcinkowska M; Bucki A; Śniecikowska J; Pawłowski M; Kazek G; Siwek A; Jastrzębska-Więsek M; Partyka A; Wasik A; Wesołowska A; Mierzejewski P; Bienkowski P
    Eur J Med Chem; 2015 Mar; 92():221-35. PubMed ID: 25557493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.